Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Lancet Diabetes Endocrinol. 2019 Sep;7(9):673-683. doi: 10.1016/S2213-8587(19)30151-2. Epub 2019 Jul 11.
For several cardiometabolic risk factors, values considered within normal range are associated with an increased risk of cardiovascular morbidity and mortality. We aimed to investigate the short-term and long-term effects of calorie restriction with adequate nutrition on these risk factors in healthy, lean, or slightly overweight young and middle-aged individuals.
CALERIE was a phase 2, multicentre, randomised controlled trial in young and middle-aged (21-50 years), healthy non-obese (BMI 22·0-27·9 kg/m) men and women done in three clinical centres in the USA. Participants were randomly assigned (2:1) to a 25% calorie restriction diet or an ad libitum control diet. Exploratory cardiometabolic risk factor responses to a prescribed 25% calorie restriction diet for 2 years were evaluated (systolic, diastolic, and mean blood pressure; plasma lipids; high-sensitivity C-reactive protein; metabolic syndrome score; and glucose homoeostasis measures of fasting insulin, glucose, insulin resistance, and 2-h glucose, area-under-the curve for glucose, and insulin from an oral glucose tolerance test) analysed in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00427193.
From May 8, 2007, to Feb 26, 2010, of 238 participants that were assessed, 218 were randomly assigned to and started a 25% calorie restriction diet (n=143, 66%) or an ad libitum control diet (n=75, 34%). Individuals in the calorie restriction group achieved a mean reduction in calorie intake of 11·9% (SE 0·7; from 2467 kcal to 2170 kcal) versus 0·8% (1·0) in the control group, and a sustained mean weight reduction of 7·5 kg (SE 0·4) versus an increase of 0·1 kg (0·5) in the control group, of which 71% (mean change in fat mass 5·3 kg [SE 0·3] divided by mean change in weight 7·5 kg [0·4]) was fat mass loss. Calorie restriction caused a persistent and significant reduction from baseline to 2 years of all measured conventional cardiometabolic risk factors, including change scores for LDL-cholesterol (p<0·0001), total cholesterol to HDL-cholesterol ratio (p<0·0001), and systolic (p<0·0011) and diastolic (p<0·0001) blood pressure. In addition, calorie restriction resulted in a significant improvement at 2 years in C-reactive protein (p=0·012), insulin sensitivity index (p<0·0001), and metabolic syndrome score (p<0·0001) relative to control. A sensitivity analysis revealed the responses to be robust after controlling for relative weight loss changes.
2 years of moderate calorie restriction significantly reduced multiple cardiometabolic risk factors in young, non-obese adults. These findings suggest the potential for a substantial advantage for cardiovascular health of practicing moderate calorie restriction in young and middle-aged healthy individuals, and they offer promise for pronounced long-term population health benefits.
National Institute on Aging and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
对于一些心血管代谢风险因素,处于正常值范围内的值与心血管发病率和死亡率的增加相关。我们旨在研究热量限制与充足营养对健康、瘦或轻度超重的年轻和中年个体这些风险因素的短期和长期影响。
CALERIE 是一项在美国三个临床中心进行的、针对年轻和中年(21-50 岁)、健康非肥胖(BMI 22.0-27.9 kg/m²)男性和女性的、2 期、多中心、随机对照试验。参与者被随机分配(2:1)到 25%热量限制饮食或随意对照饮食。评估了对规定的 25%热量限制饮食 2 年的探索性心血管代谢风险因素反应(收缩压、舒张压和平均血压;血浆脂质;高敏 C 反应蛋白;代谢综合征评分;以及空腹胰岛素、葡萄糖、胰岛素抵抗和 2 小时葡萄糖的葡萄糖稳态测量、口服葡萄糖耐量试验的葡萄糖和胰岛素的曲线下面积),在意向治疗人群中进行分析。这项研究在 ClinicalTrials.gov 上注册,编号为 NCT00427193。
从 2007 年 5 月 8 日至 2010 年 2 月 26 日,在评估的 238 名参与者中,218 名被随机分配并开始进行 25%热量限制饮食(n=143,66%)或随意对照饮食(n=75,34%)。热量限制组的个体平均减少了 11.9%(SE 0.7;从 2467 千卡减少到 2170 千卡)的热量摄入,而对照组则增加了 0.8%(1.0),平均体重减轻了 7.5 公斤(SE 0.4),而对照组则增加了 0.1 公斤(0.5),其中 71%(平均脂肪量变化 5.3 公斤[SE 0.3]除以体重变化 7.5 公斤[0.4])为脂肪量损失。热量限制导致所有常规心血管代谢风险因素从基线到 2 年的持续显著降低,包括 LDL-胆固醇(p<0.0001)、总胆固醇与高密度脂蛋白胆固醇比值(p<0.0001)、收缩压(p<0.0011)和舒张压(p<0.0001)。此外,与对照组相比,热量限制在 2 年时还导致 C 反应蛋白(p=0.012)、胰岛素敏感性指数(p<0.0001)和代谢综合征评分(p<0.0001)显著改善。敏感性分析显示,在控制相对体重减轻变化后,这些反应是稳健的。
2 年的中等热量限制显著降低了年轻非肥胖成年人的多种心血管代谢风险因素。这些发现表明,在年轻和中年健康个体中实施适度热量限制对心血管健康可能有很大的优势,并且为显著的长期人群健康益处提供了希望。
美国国立卫生研究院的国家老龄化研究所和国家糖尿病、消化和肾脏疾病研究所。